Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Epirubicin × 30 days × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER_GOV 1 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 117 Specimen Handling 106 pembrolizumab 98 Cyclophosphamide 86 Radiotherapy 73 Nivolumab 72 Cisplatin 60 Biopsy 57 Carboplatin 55 Gemcitabine 52 fludarabine 51 Surveys and Questionnaires 51 Radiosurgery 47 Blood Specimen Collection 46 Standard of Care 44 venetoclax 43 Paclitaxel 40 Radiation 38 Rituximab 37 Dexamethasone 37 Ipilimumab 35 Cytarabine 34 Bevacizumab 34 fludarabine phosphate 31 Oxaliplatin 31 Docetaxel 31 durvalumab 30 Drug Therapy 30 Interviews as Topic 29 atezolizumab 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04877821 2026-04-02

NeoSACT

Guangdong Provincial People's Hospital

Phase 2 Completed

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡